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[20] Akt/PKB is a serine-threonine kinase that plays a critical role in cell survival signaling by phosphorylating and inactivating components of the cell death machinery. Akt has been shown to phosphorylate a subfamily of forkhead transcription factors and prevent their nuclear localization, leading to repression of genes involved in apoptosis, such as Fas ligand. Other genes involved in forkhead-mediated apoptosis have yet to be identified. Using bioinformatics approaches, we have identified genes containing forkhead factor binding sites in their promoter sequences. One gene identified by this search is that coding transforming growth factor βII (TGF-βII). We show that activated Akt can downregulate TGF-βII promoter activity and that this repression is mediated by the three forkhead factor binding sites present in its promoter region. TGF-βII (but not TGF-βI) messenger RNA levels are significantly downregulated in pancreatic and breast cancer cell lines expressing activated Akt (through either gene amplification or inactivation of the PTEN/MMAC1 tumor suppressor gene). Tumor cell lines expressing activated Akt and an intact TGF-βII signaling pathway are responsive to TGF-β-mediated growth inhibition. Our studies demonstrate that repression of TGF-βII promoter in tumors expressing activated Akt is a new mechanism to abrogate the growth inhibition or apoptotic effects (or both) of TGF-β.
Identification of TGF-βII as a transcriptional target of Akt
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Gene expression profiling of oxaliplatinresistant cell lines We compared the gene expression patterns of oxaliplatin-resistant cell lines with the patterns of their sensitive counterparts in an attempt to discover universal mechanisms that characterize resistant cells. Isogenic oxaliplatin-resistant variants of four ovarian carcinoma cell lines and one squamous cell carcinoma line were selected by repeated exposures of increasing concentrations of oxaliplatin (resistance levels ranged from 4-fold to 20-fold). We harvested RNA from all five pairs and assayed gene expression through hybridization to Affymetrix HuGeneFL arrays. Using global, unsupervised, two-way hierarchical clustering we observed that resistant cell lines clustered with their corresponding parental cell lines, indicating that the number of changes in gene expression leading to resistance are probably few and that these changes are diluted in the global gene expression profile of the entire cell. In addition, Venn diagram analysis revealed that very few genes were commonly up-or downregulated across all cell lines. However, employing a recently developed supervised clustering method that uses principal component analysis to extract groups of genes with maximal variance across cell lines, we found a small cluster of genes that were consistently differentially expressed in most but not all resistant cell lines. Although this group of genes contains some interesting members, it is unlikely that these genes are the sole determinants of oxaliplatin resistance. Finally, comparison of the numbers of differentially expressed genes from each pair that were associated with specific MeSH terms supported our conclusion that no common mechanism of resistance could be detected within the five resistant pairs.
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